Three-dimensional conformai radiotherapy in combination with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma

Journal of B.U.ON.

Volumn 19, Issue 3, 2014, Pages 692-697

  Chen, Wen Jun ^a   Yuan, Shao Fei ^a   Zhu, Lin Jia ^a   Sun, Xiao Nan ^b   Zheng, Weie ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Primary hepatocellular carcinoma; Three dimensional conformai radiotherapy; Transcatheter arterial chemoembolization

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; EPIRUBICIN; FLUOROURACIL; MITOMYCIN;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG FEVER; FEMALE; FEVER; FOLLOW UP; HUMAN; LEUKOPENIA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PAIN; RADIATION DOSE; RADIATION SAFETY; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; TREATMENT DURATION; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING; ADOLESCENT; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY, CONFORMAL;

EID: 84908456621     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Tinkle CL, Haas-Kogan D. Hepatocellular carcinoma: Natural history, current management, and emerging tools. Biologies 2012;6: 207-219.
2. Rim CH, Yang DS, Park YJ, Yoon WS, Lee JA, Kim CY. Effectiveness of high-dose three-dimensional conformai radiotherapy in hepatocellular carcinoma with portal vein thrombosis. Jpn J Clin Oncol 2012;42: 721-729.
3. Kang MK, Kim MS, Kim SK et al. High-dose radiotherapy with intensity-modulated radiation therapy for advanced hepatocellular carcinoma. Tumori 2011;97: 724-731.
4. Olivo M, Valenza F, Buccellato A et al. Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: Survival rate and prognostic factors. Dig Liver Dis 2010;42: 515-519.
5. Khoynezhad A, Plestis KA. Cannulation in the diseased aorta: A safe approach using the Seldinger technique. Tex Heart Inst J 2006; 33: 353-355.
6. Jiang GL Three-dimensional conformai radiotherapy in hepatocellular carcinoma: Conclusion of eight years studies. The memoir of the sixth Chinese National Meeting of Radiation Oncology, 2007; pp 9-19.
7. Ippolito D, Bonaffini PA, Ratti L et al. Hepatocellular carcinoma treated with transarterial chemoembolization: Dynamic perfusion-CT in the assessment of residual tumor. World J Gastroenterol 2010: 16: 5993-6000.
8. Loffroy R. Interventional radiology for hepatocellular carcinoma. Minerva Gastroenterol Dietol 2011;57: 299-309.
9. Takayasu K. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: Recent progression and perspective. Oncology 2013;3: 28-33.
10. Kawamura Y, Ikeda K, Kumada H. Strategy for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization using epi-rubicin. Gan To Kagaku Ryoho 2010;37: 402-406.
11. Woo HY, Jang JW, Choi JY et al. Tumor doubling time after initial response to transarterial chemoembolization in patients with hepatocellular carcinoma. Scand J Gastroenterol 2010;45: 332-339.
12. Eun HS, Kim MJ, Kim HJ et al. The retrospective co- hort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care. Korean J Hepatol 2011;17: 189-198.
13. Hoffmann RT, Paprottka P, Jakobs TF, Trumm CG, Reiser MF. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization). Abdom Imaging 2011;36: 671-676.
14. Ursino S, Greco C, Cartei F et al. Radiotherapy and hepatocellular carcinoma: Update and review of the literature. Eur Rev Med Pharmacol Sci 2012: 16: 1599-1604.
15. Kuo YC, Chiu YM, Shih WP et al. Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: Comparison with intensity-modulated radiotherapy and 3-D conformai radiotherapy. Radiât Oncol 2011;6: 76.
16. Goryawala M, Guillen MR, Cabrerizo M et al. A 3-D liver segmentation method with parallel computing for selective internal radiation therapy. EEE Trans Inf Technol Biomed 2012;16: 62-69.
17. Merle P, Mornex F. Transarterial chemoembolization and conformai radiotherapy for hepatocellular carcinoma. Cancer Radiother 2011;15: 69-71.
18. Gong GZ, Yin Y, Xing LG et al. RapidArc combined with the active breathing coordinator provides an effective and accurate approach for the radiotherapy of hepatocellular carcinoma. Strahlenther Onkol 2012;188: 262-268.
19. Kang JK, Kim MS, Cho CK et al. Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization. Cancer 2012;118: 5424-5531.
20. Sawrie SM, Fiveash JB, Caudell JJ. Stereotactic body radiation therapy for liver metastases and primary hepatocellular carcinoma: Normal tissue tolerances and toxicity. Cancer Control 2010;17: 111-119.
21. Xu LT, Zhou ZH, Lin JH et al. Clinical study of transarterial chemoembolization combined with 3-dimen-sional conformai radiotherapy for hepatocellular carcinoma. Eur J Surg Oncol 2011;37: 245-251.
22. Yoon SM, Lim YS, Won HJ et al. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: Long-term patient outcomes. Int J Radiât Oncol Biol Phys 2012;82: 2004-2011.